03-24

2020

Chipscreen Biosciences's Original New Drug CS12192: Investigational New Drug (IND) Application Accepted

On March 23th, 2020, Shenzhen Chipscreen Biosciences Co., Ltd. (Chipscreen Biosciences, Stock Symbol: 688321.SH) announced that the company’s appl...

12-03

2019

National Medical Products Administration (NMPA) Approves Chipscreen Bioscience's Chidamide (Epidaza) for Breast Cancer Indication

On November 29, 2019, Shenzhen Chipscreen Biosciences Co., Ltd. (Chipscreen Biosciences, Stock Symbol: 688321.SH) announced that the company's lead...

10-09

2019

Chipscreen and Novogene enter a strategic partnership for companion diagnostics development

Chipscreen Biosciences Co., Ltd. (Chipscreen, Stock Symbol: 688321. SH) and Novogene Co., Ltd. (Novogene) recently announced a strategic partnershi...

09-20

2019

Chipscreeen Biosciences’s Original New Drug Bilessglu® (for Type 2 Diabetes): Commercialization Application Accepted

The new drug application (NDA) of Chiglitazar (Bilessglu®) , an innovative new chemical entity (Category 1 of chemical drug) for type 2 diabetes disc...

05-30

2018

Good News! CHIPSCREEN BIOSCIENCES Is Approved to Be Provincial Engineering Research Center

Recently, the Department of Science and Technology of Guangdong Province officially announced the list of Engineering Technology Research Centers in G...

05-19

2018

The CHIPSCREEN BIOSCIENCES was invited to participate in celebration of 40th anniversary of WHO Uppsala Monitoring Center

On May 17 to 18, 2018, the Uppsala Monitoring Center ( UMC ), WHO international drug monitoring cooperation agency, held the 40th anniversary celebra...

04-27

2018

Asian Pharmaceutical Organization Cooperation Conference ( APAC ) and Drug Development Alliance Working Group ( DA-EWG) visits the CHIPSCREEN BIOSCIENCES

On the morning of April 27, 2018, Dr. Lu Xianping, the chairman of Shenzhen Microchip Biotech co., ltd. ( hereinafter referred to as " CHIPSCREE...

04-25

2018

Master core technology and make China's own innovative medicine - Dr. Lu Xianping, the chairman of CHIPSCREEN BIOSCIENCES, won " 2017 China pharmaceutical development award for outstanding achiev

On April 25, 2018, the 2017 China pharmaceutical development award ceremony was solemnly held in Beijing's Chinese Science and Technology Hall. Sang G...

04-12

2018

Dr. Lu was invited to attend the first global forum of 30 Chinese scientists for innovation and transformation

On April 9, 2018, the first global forum of 30 Chinese scientists for innovation and transformation and the "2018 Excellence and Innovation and Transforma...

01-03

2018

Dr. Lu, the president of CHIPSCREEN BIOSCIENCES and the company, were honored with " 2017 Let Love Go Home Project"

On December 31, 2017, the honor and public welfare performance of the " Thank Guangdong and Love Bashu", 2017 Let Love Go Home Project sponsored by t...